Services
Report Store
Market Insights
Our Blogs
Connect with Us

Buy Now

Aspartic Acid Market

Pages: 130 | Base Year: 2024 | Release: July 2025 | Author: Sharmishtha M.

Market Definition

Aspartic acid, a non-essential amino acid, is vital for protein synthesis, neurotransmission, and hormone regulation. It is naturally present in the human body and in foods such as meat, dairy, and vegetables. In addition to natural sources, it can be synthetically produced.

Synthetic aspartic acid is manufactured using various chemical or biotechnological methods, such as fermentation processes involving bacteria or chemical synthesis from other organic compounds. The market encompasses its production, technological advancements, and commercial distribution.

Aspartic Acid Market Overview

The global aspartic acid market size was valued at USD 110.3 million in 2024, which is estimated to be valued at USD 116.2 million in 2025 and reach USD 170.6 million by 2032, growing at a CAGR of 5.56% from 2025 to 2032.

Major companies operating in the aspartic acid industry are Evonik Industries AG, Prinova Group LLC, IRIS BIOTECH GMBH, AnaSpec, KYOWA HAKKO BIO CO.,LTD., Ajinomoto Co., Inc., Aditya Chemicals, Kishida Chemical Co.,Ltd, Alpha Chemika, Shijiazhuang Jirong Pharmaceutical Co., Ltd., AVANSCHEM, NACALAI TESQUE, INC., Alpspure Lifesciences Pvt. Ltd., Naugra , and Central Drug House.

The market is witnessing robust growth, fueled by rising demand for biodegradable additives, dietary supplements, and pharmaceutical applications. Increased consumer interest in health and wellness, along with a shift toward sustainable and natural ingredients, is boosting adoption across industries.

Manufacturers are focusing on product innovation and improved production processes to meet evolving market needs and capitalize on new opportunities. The market’s versatility and alignment with clean-label trends further support its positive outlook.

  • In February 2023, researchers from Shaanxi University of Science and Technology (China) and Semmelweis University (Budapest) developed PASP-l-PAHy, an innovative injectable, self-biodegradable hydrogel based on semi-synthetic poly (aspartic acid). This hydrogel mimics the structure and flexibility of skin, enabling it to fill irregular wounds, adhere stably, and biodegrade naturally without causing secondary injury.  Animal studies demonstrated its effectiveness in accelerating wound healing and promoting tissue regeneration, indicating strong potential as a next-generation, minimally invasive wound dressing.

Aspartic Acid Market Size & Share, By Revenue, 2025-2032

Key Highlights:

  1. The aspartic acid industry size was recorded at USD 110.3 million in 2024.
  2. The market is projected to grow at a CAGR of 5.56% from 2025 to 2032.
  3. North America held a market share of 35.95% in 2024, with a valuation of USD 39.7 million.
  4. The D-aspartic acid segment garnered USD 42.6 million in revenue in 2024.
  5. The food segment is expected to reach USD 1 million by 2032.
  6. Asia Pacific is anticipated to grow at a CAGR of 6.41% over the forecast period.

Market Driver

Expanding Pharmaceutical Applications

The expansion of pharmaceutical applications is fostering the growth of the aspartic acid market. Its role in protein synthesis and neurotransmission makes it essential in drug formulations, particularly targeting neurological health, cognitive function, and hormone regulation.

The rising prevalence of neurological disorders and the ongoing demand for innovative therapies and nutritional supplements are prompting pharmaceutical companies to expand its use, thereby fueling market growth.

Researchers from İzmir Katip Çelebi University and Bogazici University (Turkey) investigated the effects of modifying synthetic nanofiber scaffolds with biomimetic aspartic acid and glutamic acid peptides to enhance bone tissue engineering. Their findings indicate that aspartic acid peptide-modified scaffolds significantly improve cell adhesion, osteogenic differentiation, and mineralization, supporting advancements in bone regeneration therapies.

Market Challenge

High Production Costs

High production costs, driven by expensive raw materials and complex manufacturing processes, present a significant challenge to the expansion of the aspartic acid market, often limiting profitability and scalability for producers.These factors not only reduce profit margins but also hinder large-scale production, particularly for small and medium-sized manufacturers.

Additionally, the need for advanced purification techniques further adds to operational expenses, limiting the market's scalability and competitiveness in cost-sensitive end-use industries like food, pharmaceuticals, and biodegradable polymers.

To address this challenge, companies are increasingly investing in research and development to optimize production methods, such as adopting more efficient biotechnological processes or utilizing alternative, cost-effective raw materials. These innovations help streamline manufacturing, reduce expenses, and enhance the accessibility of aspartic acid across various industries.

Market Trend

Widespread Adoption of Efficient Production Methods

A key trend shaping the aspartic acid market is the adoption of efficient, cost-effective, and environmentally friendly production methods, particularly biotechnological and fermentation. These innovations help manufacturers reduce environmental impact, lower production costs, and improve product purity. This supports rising demand across food, pharmaceutical, and industrial sectors, supporting market expansion and aligning with global sustainability goals.

  • In Jan 2025, researchers from Shiraz University of Medical Sciences and Iran University of Science and Technology (IUST) developed an eco-friendly nanocatalyst by stabilizing aspartic acid on magnetic nanoparticles. This innovation highlights the shift toward efficient, reusable, and sustainable production methods in pharmaceutical and chemical synthesis.

Aspartic Acid Market Report Snapshot

Segmentation

Details

By Product

L-Aspartic Acid, D-Aspartic Acid, DL-Aspartic Acid

By End Use

Food, Beverages, Cosmetics, Pharmaceuticals, Agriculture/Animal Feed, Others

By Region

North America: U.S., Canada, Mexico

Europe: France, UK, Spain, Germany, Italy, Russia, Rest of Europe

Asia-Pacific: China, Japan, India, Australia, ASEAN, South Korea, Rest of Asia-Pacific

Middle East & Africa: Turkey, U.A.E., Saudi Arabia, South Africa, Rest of Middle East & Africa

South America: Brazil, Argentina, Rest of South America

Market Segmentation:

  • By Product (L-Aspartic Acid, D-Aspartic Acid, and DL-Aspartic Acid): The D-aspartic acid segment earned USD 42.6 million in 2024, mainly due to its growing use in dietary supplements and pharmaceutical formulations.
  • By End Use (Food, Beverages, Cosmetics, Pharmaceuticals, Agriculture/Animal Feed, and Others): The food segment held a share of 29.90% in 2024, fueled by increased demand for functional foods and natural amino acid-based additives.

Aspartic Acid Market Regional Analysis

Based on region, the market has been classified into North America, Europe, Asia Pacific, Middle East & Africa, and South America.

Aspartic Acid Market Size & Share, By Region, 2025-2032

The North America aspartic acid market share stood at 35.95% in 2024, valued at USD 39.7 million. This dominance is reinforced by the region's advanced pharmaceutical, food and beverage, and biotechnology sectors. High consumer awareness of health and wellness, robust demand for dietary supplements and functional foods, and strong research and development activities further support this growth.

Additionally, the presence of major industry players and established distribution networks is boosting regional market growth, while ongoing innovations and supportive government policies are expanding aspartic acid applications.

The Asia-Pacific aspartic acid industry is estimated to grow at a CAGR of 6.41% over the forecast period. This growth is fueled by increasing demand from the food, pharmaceutical, and biotechnology sectors, coupled with rising health awareness and industrialization.

The regional market benefits from a strong manufacturing base, growing investments in research and development, and expanding applications of aspartic acid in dietary supplements and functional foods.

Regulatory Frameworks

  • In the U.S., the Food and Drug Administration (FDA) oversees dietary supplements through its Human Foods Program's Office of Food Chemical Safety, Dietary Supplements, and Innovation. Under the Dietary Supplement Health and Education Act (DSHEA) of 1994, manufacturers must ensure their products are safe and properly labeled before marketing.
  • In the EU, Directive 2002/46/EC regulates the use of aspartic acid in dietary supplements, focusing on safety, labeling, and permissible ingredients to ensure compliance and protect consumers from misleading claims.
  • Globally, the Codex Alimentarius Commission (CAC), established by the Food and Agriculture Organization (FAO) and the World Health Organization (WHO) in 1963,  sets international food standards to safeguard consumer health and promote fair trade, covering areas such as pesticides, additives, and contaminants.

Competitive Landscape

Companies in the aspartic acid industry are prioritizing sustainable innovation through biotechnological and fermentation techniques. They are expanding applications in food, pharmaceuticals, and biodegradable materials, while enhancing product quality and purity.

Strategic investments in research and development, enhanced distribution networks, and alignment with consumer demand for natural and health-oriented products are enabling companies to remain competitive and capitalize on emerging opportunities.

List of Key Companies in Aspartic Acid Market:

  • Evonik Industries AG
  • Prinova Group LLC
  • IRIS BIOTECH GMBH
  • AnaSpec
  • KYOWA HAKKO BIO CO.,LTD.
  • Ajinomoto Co., Inc.
  • Aditya Chemicals
  • Kishida Chemical Co.,Ltd
  • Alpha Chemika
  • Shijiazhuang Jirong Pharmaceutical Co., Ltd.
  • AVANSCHEM
  • NACALAI TESQUE, INC.
  • Alpspure Lifesciences Pvt. Ltd.
  • Naugra
  • Central Drug House

Recent Developments (Restructuring)

  • In October 2024, Evonik announced a strategic shift impacting the market by evaluating partnerships or divestments for its amino acid production sites. The company’s move to discontinue certain operations and focus on core growth areas is expected to influence aspartic acid supply, market competition, and future industry developments.
Loading FAQs...